The structural astrocyte marker GFAP and the transcription factor OLIG2 were inferred to be upregulated in late-stage AD, and vimentin was inferred to be downregulated in the AD mouse astrocytes. This evidence concerns the gene OLIG2 and Alzheimer disease.